|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61L 31/06 | |
| A61L 31/16 | |||
| A61K 31/216 | |||
| A61K 9/00 | |||
| A61K 9/20 | |||
| A61K 31/557 | |||
| A61K 31/5575 | |||
| A61K 9/16 |
| (11) | Number of the document | 2358349 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09748186.5 |
| Date of filing the European patent application | 2009-10-23 | |
| (97) | Date of publication of the European application | 2011-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/061798 |
| Date | 2009-10-23 |
| (87) | Number | WO 2010/062523 |
| Date | 2010-06-03 |
| (30) | Number | Date | Country code |
| 259153 | 2008-10-27 | US |
| (72) |
ROBINSON, Michael R., US
LIU, Hui, US
HUGHES, Patrick M., US
SPADA, Lon T., US
GHEBREMESKEL, Alazar N., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF |
| PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF |